Madrigal to Present New Data from the Company’s MASH Program at AASLD’s The Liver Meeting 2025
Madrigal to Present New Data from the Company's MASH Program at AASLD's The Liver Meeting 2025 GlobeNewswire October 28, 2025 Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of Rezdiffra Poster of distinction examines the impact of Rezdiffra interruption […]